Ecthyma gangrenosum secondary to Staphylococcus aureus in an infant with transient neutropenia

Pediatric Dermatology
Patricia M PechterBrian Berman

Abstract

Ecthyma gangrenosum is classically a cutaneous manifestation of a pseudomonal septicemia that presents in a patient with an immunodeficiency or hematologic malignancy. We describe a previously healthy 8-month-old girl who developed transient neutropenia and characteristic ecthyma gangrenosum lesions secondary to methicillin-resistant Staphylococcus aureus. This unique presentation of methicillin-resistant Staphylococcus aureus ecthyma gangrenosum emphasizes the importance of broad empiric coverage and early culturing for microorganism and susceptibilities in any patient presenting with ecthyma gangrenosum.

References

Feb 3, 1979·Canadian Medical Association Journal·M FastW Albritton
Dec 1, 1986·Burns, Including Thermal Injury·J P EldridgeB G MacMillan
Feb 1, 1987·Archives of Internal Medicine·D HuminerS D Pitlik
Aug 1, 1985·Journal of the American Academy of Dermatology·P el Baze, J P Ortonne
Oct 1, 1971·Archives of Internal Medicine·G J DorffM W Rytel
Apr 21, 2004·Journal of the American Academy of Dermatology·Hilary L ReichAlbert C Yan
Sep 27, 2005·The British Journal of Dermatology·K S LeslieN J Levell
Sep 30, 2005·Pediatric Dermatology·Tomoaki IshikawaAkira Yoshioka
Jan 11, 2007·Journal of Burn Care & Research : Official Publication of the American Burn Association·Douglas M DowneyJonathan M Saxe
Nov 26, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hüseyin SenGüner Dağli

❮ Previous
Next ❯

Citations

Jan 12, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·L WuytsO Aerts
May 8, 2014·Journal of Cutaneous Medicine and Surgery·Federico Maria GioacchiniMatteo Alicandri-Ciufelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.